Delivery Order 75N91023D00002-75N91023F00002
Award Date
4/1/23
Potential Completion Date
3/31/28
Potential Value
$1.8M
Federal Agency
National Cancer Institute
Awardee
Fisher Bioservices Inc.
Ultimate Awardee
Thermo Electron Corporation
PSC Category
S215 - Housekeeping- Warehousing/Storage
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the National Cancer Institute (NCI) to Fisher Bioservices Inc., a subsidiary of Thermo Electron Corporation. The $117,869.61 task order is for the registration, storage, and distribution of chemicals and drugs to support pre-clinical discovery, evaluation, and development. This is part of a larger single-award $19 million indefinite delivery contract between Fisher Bioservices and NCI for operating and maintaining the NCI's Chemotherapeutic...
This is a $11,167,035.62 Cost Plus Fixed Fee delivery order contract awarded by the National Cancer Institute (NCI) to Fisher Bioservices Inc., a subsidiary of Thermo Electron Corporation. The contract is for the registration, storage, and distribution of chemicals and drugs to support pre-clinical discovery, evaluation, and development. It is part of a larger $19 million single-award Indefinite Delivery Vehicle (IDV) contract between NCI and Fisher Bioservices for these services. The contract...
This is a $38,122,538.00 definitive contract awarded by the National Cancer Institute (NCI) to Fisher BioServices Inc., a subsidiary of Thermo Electron Corporation. The contract is for the storage and distribution of clinical agents supporting cancer clinical trials over a period of 5 years, ending on January 31, 2028. The contract is a cost-plus-fixed-fee arrangement, and there was no set-aside designation used for this requirement. The original solicitation was for capability statements from...
This is a federal contract awarded by the National Cancer Institute (NCI), a civilian agency, to Fisher Bioservices Inc. Clinical Trials Division, a subsidiary of Thermo Electron Corporation. The $81,331,761.57 definitive, cost-plus-fixed-fee contract is for the storage and distribution of chemicals and drugs used in preclinical evaluation and development. The contract has an ultimate completion date of February 29, 2008 and was awarded on August 1, 2002 without a set-aside designation. The...
This is a definitive contract awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Fisher Bioservices Inc., a division of Thermo Electron Corporation, for the storage and distribution of clinical agents. The contract has a potential value of $29,398,963.86 and is a cost plus fixed fee arrangement. The contract does not have a set-aside designation. As a prime contractor, Fisher Bioservices provides a variety of goods and services to...
This federal contract award, valued at $149,777.24, was made by the National Cancer Institute (NCI) to Fisher Bioservices Inc., a subsidiary of Thermo Electron Corporation. The contract is for off-site storage of refrigerated, cryopreserved, and frozen biological materials. This delivery order contract is part of the Scientific Equipment and Services (FSS-66) schedule under the General Services Administration (GSA). The contract does not have a set-aside designation. Fisher Bioservices is an...
This is a delivery order awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Fisher Bioservices Inc. for the storage and management of monoclonal antibodies and interleukin-15 for use in clinical trials. The $1,083.30 firm-fixed-price contract is for option period 3 of the original agreement, with a period of performance ending on May 31, 2017. Fisher Bioservices is a subsidiary of Thermo Electron Corporation and has extensive experience...
This is a federal contract award from the National Cancer Institute (NCI), a civilian agency, to Fisher Bioservices Inc.'s Clinical Trials Division, a subsidiary of Thermo Electron Corporation. The contract is for the registration, storage, and distribution of chemicals and drugs for pre-clinical discovery evaluation and development, with a ceiling value of $78,987.04. The contract is a delivery order under a larger indefinite delivery vehicle (IDV) contract valued at $19 million, which involves...
This federal contract award to Fisher Bioservices Inc., a subsidiary of Thermo Electron Corporation, is valued at $11,793,466.15. The contract is for the web-based acquisition, receipt, storage, inventory, distribution, documentation, and control of synthetic compounds, purified natural products, and bulk drugs to support the National Cancer Institute's chemotherapeutic agent evaluation program. The contract is a Cost Plus Fixed Fee Definitive Contract without a set-aside designation. It...
This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency, to Fisher Bioservices Inc. for the storage of cryopreserved cells for a period of one year. The contract is valued at $78,265.52 and is not set aside. Fisher Bioservices Inc. is a subsidiary of Thermo Electron Corporation, which is a major provider of scientific instruments and services to federal agencies. This contract is part of Fisher Bioservices' broader work supporting...